Cassava Sciences Inc SAVA

Healthcare

Cassava Sciences, Inc. is a biotechnology company focused on Alzheimer's disease. The Company's science is based on stabilizing, but not removing, a critical protein in the brain. The Company is focused on its product discovery and development efforts on disorders of the nervous system. Its lead therapeutic drug candidate, simufilam, is under clinical evaluation for the proposed treatment of Alzheimer's disease dementia in Phase 3 clinical studies. The Company has two biopharmaceutical assets under development. Its lead therapeutic product candidate, called simufilam, is an oral treatment for Alzheimer's disease dementia. Its lead investigational diagnostic product candidate, called SavaDx, is a way to detect the presence of Alzheimer's disease from a small sample of blood. Simufilam targets an altered form of a protein called filamin A in the Alzheimer's brain. It owns rights to its drug and diagnostic assets and related technologies, without royalty obligations to any third party.

NDAQ:SAVA - Post by User

Cassava Sciences Inc

<< Previous

Bullboard Posts

Next >>

Post by ProTrader301on Sep 24, 2021 9:49am

242 Views

Post# 33913418

Low float means the ride back up will be just as quick.

Low float means the ride back up will be just as quick. Especially once the CP is tossed out. Add start of Ph 3 and possibly a major partnership and SAVA will have a new all time high in Q4!! I would not want to trade without this amazing tool. The instant news availability, the level of detail you can access quickly, and continuous updating of features are all excellent. https://bit.ly/3o0Q4cg

<< Previous

Bullboard Posts

Next >>

This gambling tech stock might be the safest bet you’ll make this year